Clinical Trial

Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD

Name: Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD — clinical trial record (NCT07194863)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EssenMAFLD

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-09-19; most recent amendment 2026-01-11.

Trial Details

NCT Number	NCT07194863
Lead Sponsor	Assiut University
Conditions	Essential Phospholipid in Metabolic Associated Fatty Liver Disease
Enrollment	200 participants
Start Date	2026-11-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-13